![Iwona Tongbhoyai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Iwona Tongbhoyai
Vorstandsvorsitzender bei Synexus Clinical Research GmbH
Ursprung des Netzwerks ersten Grades von Iwona Tongbhoyai
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Synexus Clinical Research GmbH
![]() Synexus Clinical Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Synexus Clinical Research GmbH is a clinical research organization based in Leipzig, Germany. The CEOs are Radoslaw Janiak, Marcin Gondek, Iwona Tongbhoyai. The German company was founded in 1992. Synexus Clinical Research was acquired by Synexus Clinical Research Ltd., part of Thermo Fisher Scientific, Inc. from June 08, 2016 on January 12, 2010.
2
| Subsidiary | Miscellaneous Commercial Services | 2 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Iwona Tongbhoyai
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Synexus Clinical Research Ltd.
![]() Synexus Clinical Research Ltd. Medical/Nursing ServicesHealth Services Synexus Clinical Research Ltd. offers clinical trials and biological research services. It offers clinical trial management, project management, medical imaging and medical procedures. The company was founded in 1998 and is headquartered in Lancashire, the United Kingdom. | Medical/Nursing Services | President | |
Future Meds Ltd.
![]() Future Meds Ltd. Miscellaneous Commercial ServicesCommercial Services Future Meds Ltd. is a fast-growing independent research site network that supports pharmaceutical companies, sponsors, and CROs in finding effective treatments and medications for patients. The private company is based in Bromborough, UK, and has subsidiaries in Germany and the United Kingdom. The British company's dedicated research site teams aim to accelerate study timelines, streamline processes, lower costs, and improve data quality to help patients access new treatments faster. Future Meds is a network of modern dedicated research sites that conduct clinical trials using innovative technologies to make them available to as many patients as possible. The company was founded in 2020, and Radoslaw Janiak has been the CEO since 2019. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistik
International
Vereinigtes Königreich | 3 |
Sektoral
Health Services | 2 |
Commercial Services | 2 |
Operativ
Chief Executive Officer | 3 |
Chief Operating Officer | 1 |
Corporate Officer/Principal | 1 |
President | 1 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Radoslaw Janiak | 3 |
Marcin Gondek | 1 |
- Börse
- Insiders
- Iwona Tongbhoyai
- Unternehmensverbindungen